113 related articles for article (PubMed ID: 2996970)
21. Nucleotide regulation of vasoactive intestinal peptide binding to bovine thyroid plasma membranes.
Calvo JR; Morales MF; Mesa JC; Goberna R
Biosci Rep; 1990 Dec; 10(6):519-25. PubMed ID: 2085668
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ
Peptides; 1994; 15(2):309-15. PubMed ID: 8008637
[TBL] [Abstract][Full Text] [Related]
23. Direct demonstration of guanine nucleotide sensitive receptors for vasoactive intestinal peptide in the anterior lobe of the rat pituitary gland.
Agui T; Matsumoto K
Peptides; 1990; 11(3):609-11. PubMed ID: 2166281
[TBL] [Abstract][Full Text] [Related]
24. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822
[TBL] [Abstract][Full Text] [Related]
25. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
[TBL] [Abstract][Full Text] [Related]
27. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
28. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
Paul S; Said SI
J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
[TBL] [Abstract][Full Text] [Related]
29. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
30. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal polypeptide: specific binding to rat brain membranes.
Taylor DP; Pert CB
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):660-4. PubMed ID: 218214
[TBL] [Abstract][Full Text] [Related]
32. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
33. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
34. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
35. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
Couvineau A; Laburthe M
Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841
[TBL] [Abstract][Full Text] [Related]
36. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form.
Voisin T; Couvineau A; Guijarro L; Laburthe M
Life Sci; 1991; 48(2):135-41. PubMed ID: 1847224
[TBL] [Abstract][Full Text] [Related]
37. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.
Binder HJ; Lemp GF; Gardner JD
Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588
[TBL] [Abstract][Full Text] [Related]
38. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.
Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J
Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
